Professor Andreas Obermair MDVIE, FRANZCOG, CGO Make an Enquiry

Publications

Clinical Research

Obermair A, Mileshkin L, Bolz K, Kondalsamy-Chennakesavan S, Cheuk R, Vasey P, Wyld D, Goh J, Nicklin JL, Perrin LC, Sykes P, Janda M. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma. Gynecol Oncol. 2011 Feb;120(2):179-84.

Janda M, Gebski V, Brand A, Hogg R, Jobling TW, Land R, Manolitsas T, McCartney A, Nascimento M, Neesham D, Nicklin JL, Oehler MK, Otton G, Perrin L, Salfinger S, Hammond I, Leung Y, Walsh T, Sykes P, Ngan H, Garrett A, Laney M, Ng TY, Tam K, Chan K, Wrede CD, Pather S, Simcock B, Farrell R, Obermair A. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial. Lancet Oncol. 2010 Aug; 11(8): 772-80.

Obermair A, Youlden DR, Young JP, Lindor NM, Baron JA, Newcomb P, Parry S, Hopper JL, Haile R, Jenkins MA. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer. 2010 Dec 1; 127 (11):2678-84.

Gordon LG, Obermair A. Potential hospital cost-savings attributed to improvements in outcomes for colorectal cancer surgery following self-audit. BMC Surg. 2010 Jan 27;10:4.

See a full list of Professor Obermair's Clinical Research Publications

Translational Research

Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC; Australian Cancer Study Group; Australian Ovarian Cancer Study Group. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer. 2008 Nov;44(16):2477-84. Epub 2008 Aug 15.

Olsen CM, Nagle CM, Whiteman DC, Purdie DM, Green AC, Webb PM; Australian Cancer Study (Ovarian Cancer) and Australian Ovarian Cancer Study Group. Body size and risk of epithelial ovarian and related cancers: a population-based case-control study. Int J Cancer. 2008 Jul 15;123(2):450-6.

See a full list of Professor Obermair's Translational Research Publications

Tumour Angiogenesis

Mayerhofer K, Lozanov P, Bodner K, Bodner-Adler B, Obermair A, Kimberger O, Czerwenka K. Ki-67 and vascular endothelial growth factor expression in uterine leiomyosarcoma. Gynecol Oncol 2004;92:175-9.

Stimpfl M, Tong D, Fasching B, Schuster E, Obermair A, Leodolter S, Zeillinger R.Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Clin Cancer Res 2002;8:2253-9.

Bachtiary B, Selzer E, Knocke TH, Poetter R, Obermair A: Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival. Cancer Lett. 2002 May 28;179(2):197-203

See a full list of Professor Obermair's Tumor Angiogenesis Publications

Other Areas of Research

Obermair A. Is surgical literature relevant? Int J Gynecol Cancer. 2010 Nov;20(8):1300.

Hammond I, Taylor J, Obermair A, McMenamin P. The anatomy of complications workshop: an educational strategy to improve the training and performance of fellows in gynecologic oncology. Gynecol Oncol 2004;94:769-73.

Janda M, Stanek C, Newman B, Obermair A, Trimmel M: Impact of videotaped information on frequency and confidence of breast self-examination. Breast Cancer Res Treat. 2002;73:37-43.

Umek WH, Laml T, Stutterecker D, Obermair A, Leodolter S, Hanzal E: The Urethra During Pelvic Floor Contraction: Observations on Three-Dimensional Ultrasound. Obstet Gynecol 2002; 100:796-800.

Schindl M, Birner P, Obermair A, Kiesel L, Wenzl R: Increased microvessel density in adenomyosis uteri. Fertil Steril 2001; 75: 131-135.

Hefler L, Obermair A, Husslein P, Kainz C, Tempfer C: Vascular endothelial growth factor serum levels in pregnancy and preeclampsia. Acto Obstet Gynecol Scand 2000; 79: 77-78.

Kurz CHernandez E, Obermair A, Hoskins PJ, Magrina JF, McLellan R. Controversies in the management of endometrial cancer. Obstet Gynecol Int. 2010;2010. pii: 894587. Epub 2010 Aug 19., Salzer H, Arbeiter K, Obermair A, Salzer HR, Lohninger A: L-Carnitin-Betamethason Kombinationstherapie versus alleiniger Betamethasontherapie als Prophylaxe des Atemnotsyndroms. Z Geburtsh Perinat. 1993; 197: 215-219. [German]

Aichberger L, Boldizsar B, Herczeg S, Obermair A, Plckinger B, Strohmer H, Vatanparast S, Kemeter P, Feichtinger F: Die vaginosonografische Beobachtung von Uteruskontraktionen beim Embryotransfer und ihre Relevanz im Hinblick auf den Behandlungserfolg; Geburtshilfe und Frauenheilkunde 1991; 51: 27-30. [German]

Obermair A: Die Erstellung einer gynkologisch-onkologischen Patientendatei fr die Nachsorge; Wiener Klin. Wochenschrift 1991; 103: 371-373. [German]

Seifert M, Adler A, Obermair A, Hartmann B, Denison U, Kubista E, Sevelda P: Mglichkeiten und Ziele der Tumornachsorge beim Mammakarzinom. Gynkol Geburtsh Rundsch 1991; 31: 309-311. [German]

Reviews and Book Chapters

Hernandez E, Obermair A, Hoskins PJ, Magrina JF, McLellan R. Controversies in the management of endometrial cancer. Obstet Gynecol Int. 2010;2010. pii: 894587. Epub 2010 Aug 19.

Obermair A: Angiogenese und Prognose beim Mammakarzinom. In: Prognostische und therapierelevante Faktoren beim Mammakarzinom. Ergebnisse einer Konsensuskonferenz. S. Classen, H. Graeff, F. Jnicke, H. Sauer, W. Wilmanns (Hrsg.). Excerpta Oncologica Vol 6, pp 101-109. Novartis Pharma Verlag, Nrnberg 1997. [German]

Obermair A, Preyer O, Leodolter S: Angiogenese in Gynkologie und Geburtshilfe. Wien Klin Woschr 1999; 111: 262-277.

Obermair A, Preyer O, Leodolter S: Tumor angiogenesis and its relation to prognosis in epithelial ovarian cancer. CME Journal of Gynecologic Oncology 1999; 4: 169-177.

Obermair A, Preyer O, Bachtiary B: Angiogenesis in cervical cancer. CME Journal of Gynecologic Oncology 2001; 6:184-191.